WADA prohibits ibutamoren at all times under its S2 category (peptide hormones, growth factors, related substances and mimetics), so tested athletes face sanctions for any use
Understanding why these peptides complement each other helps inform decisions about combined use
Proposed Mechanisms Preventing GABA receptor downregulation Counteracting compensatory NMDA glutamate receptor sensitization Stabilizing benzodiazepine receptor configuration (preventing shift to inverse agonist state) Upregulating GABAergic neurotransmission through pathways distinct from benzodiazepine action itself This tolerance prevention has profound clinical implications
Castilla-Cortzar I, Garca-Fernndez M, Delgado G, Puche JE, Sierra I, Barhoum R, Gonzlez-Barn S
This is a critical step in preventing contamination
What is the cost difference between running tirzepatide monotherapy versus stacking it with 5-amino-1MQ